Ameriprise Financial Inc Esperion Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $61 - $102	12 Added 0.03%	42,951 $267,000
Q3 2022 Nov 14, 2022	SELL	$5.45 - $8.13 $10,736 - $16,016	-1,970 Reduced 4.39%	42,939 $287,000
Q2 2022 Aug 15, 2022	BUY	$4.77 - $6.67 $126,452 - $176,821	26,510 Added 144.08%	44,909 $286,000
Q1 2022 May 16, 2022	SELL	$3.34 - $5.56 $314,778 - $524,002	-94,245 Reduced 83.67%	18,399 $86,000
Q4 2021 Feb 14, 2022	BUY	$4.81 - $11.92 $541,817 - $1.34 Million	112,644 New	112,644 $564,000
Q2 2020 Aug 14, 2020	SELL	$30.04 - $51.31 $179,729 - $306,987	-5,983 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$27.44 - $73.84 $164,173 - $441,784	5,983 New	5,983 $327,000
Q3 2019 Nov 14, 2019	SELL	$34.47 - $47.53 $883,810 - $1.22 Million	-25,640 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$40.1 - $52.33 $5,814 - $7,587	145 Added 0.57%	25,640 $1.19 Million
Q1 2019 May 15, 2019	SELL	$40.11 - $53.57 $2,807 - $3,749	-70 Reduced 0.27%	25,495 $1.02 Million
Q4 2018 Feb 14, 2019	BUY	$36.99 - $59.11 $606,636 - $969,404	16,400 Added 178.94%	25,565 $1.18 Million
Q3 2018 Nov 14, 2018	BUY	$40.74 - $51.41 $373,382 - $471,172	9,165 New	9,165 $406,000
Q2 2018 Aug 14, 2018	SELL	$36.2 - $76.4 $777,286 - $1.64 Million	-21,472 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$65.94 - $80.76 $248,066 - $303,819	-3,762 Reduced 14.91%	21,472 $1.55 Million
Q4 2017 Feb 12, 2018	BUY	$43.47 - $67.43 $13,953 - $21,645	321 Added 1.29%	25,234 $1.66 Million
Q3 2017 Nov 07, 2017	BUY	$43.8 - $52.77 $1.09 Million - $1.31 Million	24,913	24,913 $1.25 Million

208

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $160M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.